Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...

Bite Size Bulletins

Follow us on Linkedin and Twitter. Transpharmation's CEO, Mark Duxon, along with many of his team members are active on LinkedIn and we regularly post about new studies, collaborations, innovative poster publications and much more besides. Please see our team page to see who you'd like to be connected to and you will be amongst the first to have news delivered straight to your LinkedIn news feed and be able to direct your conversation with the most suitable person.

Follow Transpharmation on LinkedIn and Twitter to keep up with all the latest news.linkedintwitter




Start a Conversation

uk flag +44 (0)20 7691 0984

ireland flag +353 (0)1896 42 60

poland flag +48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design